Literature DB >> 17360132

Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.

Marina De Rosa1, Gemma Morelli, Elena Cesaro, Francesca Duraturo, Mimmo Turano, Giovanni B Rossi, Paolo Delrio, Paola Izzo.   

Abstract

Familial adenomatous polyposis (FAP) is a rare precancerous condition caused by mutations in the adenomatous polyposis coli (apc) gene. Alternative splicing mechanisms involving non-coding and coding exons result in multiple protein variants whose molecular weight ranges between 90 and 300 kDa. We examined the apc 5' coding region and identified nine new transcripts generated from alternative and/or aberrant splicing. Three of these preserve the reading frame and the corresponding proteins include the catalytic domains and the sequences required for beta-catenin regulation. The other six transcripts create a frameshift that produces a premature stop codon; one of these has an additional 77-nucleotide-long exon (1A) between exons 1 and 2 that leads to a frameshift and a premature stop codon in exon 2. Quantitative PCR analysis suggests that the expression of this transcript is regulated during colorectal cancer tumorigenesis and differentiation. Nonsense-mediated mRNA decay (NMD) is a eukaryotic mRNA surveillance mechanism that detects and degrades mRNAs that have premature termination codons (PTCs). Expression of splicing variants containing PTCs and their subsequent degradation via NMD seems to be a general mechanism of gene regulation. Incubation of Caco2 cell lines with cycloheximide, a chemical inhibitor of translation that is known to inhibit also NMD, indicates that the apc mRNA isoform that includes exon 1A is degraded by NMD, thereby suggesting that regulated unproductive splicing and NMD degradation could modulate APC protein expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360132     DOI: 10.1016/j.gene.2006.10.027

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms.

Authors:  James M Amos-Landgraf; Amy A Irving; Cory Hartman; Anthony Hunter; Brianna Laube; Xiaodi Chen; Linda Clipson; Michael A Newton; William F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

2.  Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response.

Authors:  Lawrence B Gardner
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

3.  Novel mutations of the APC gene and genetic consequences of splicing mutations in the Czech FAP families.

Authors:  Lucie Schwarzová; Jitka Štekrová; Martina Florianová; Aleš Novotný; Michaela Schneiderová; Petr Lněnička; Věra Kebrdlová; Jaroslav Kotlas; Kamila Veselá; Milada Kohoutová
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

4.  Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis.

Authors:  Martina Galatola; Erasmo Miele; Caterina Strisciuglio; Lorella Paparo; Daniela Rega; Paolo Delrio; Francesca Duraturo; Massimo Martinelli; Giovanni Battista Rossi; Annamaria Staiano; Paola Izzo; Marina De Rosa
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

5.  Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

Authors:  A Rohlin; Y Engwall; K Fritzell; K Göransson; A Bergsten; Z Einbeigi; M Nilbert; P Karlsson; J Björk; M Nordling
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

6.  Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.

Authors:  S Yao; S J Ireland; A Bee; C Beesley; S S Forootan; A Dodson; T Dickinson; P Gerard; L-Y Lian; J M Risk; P Smith; M I Malki; Y Ke; C S Cooper; C Gosden; C S Foster
Journal:  Br J Cancer       Date:  2012-05-29       Impact factor: 7.640

7.  Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome.

Authors:  Paola Izzo; Marina De Rosa; Lorella Paparo; Giovanni Battista Rossi; Paolo Delrio; Daniela Rega; Francesca Duraturo; Raffaella Liccardo; Mario Debellis
Journal:  Hered Cancer Clin Pract       Date:  2013-07-25       Impact factor: 2.857

Review 8.  Exon identity crisis: disease-causing mutations that disrupt the splicing code.

Authors:  Timothy Sterne-Weiler; Jeremy R Sanford
Journal:  Genome Biol       Date:  2014-01-23       Impact factor: 13.583

Review 9.  Aberrant alternative splicing is another hallmark of cancer.

Authors:  Michael Ladomery
Journal:  Int J Cell Biol       Date:  2013-09-11

10.  A novel actin mRNA splice variant regulates ACTG1 expression.

Authors:  Meghan C Drummond; Karen H Friderici
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.